These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 12821856

  • 1. Comparison of multiple sclerosis lesions at 1.5 and 3.0 Tesla.
    Sicotte NL, Voskuhl RR, Bouvier S, Klutch R, Cohen MS, Mazziotta JC.
    Invest Radiol; 2003 Jul; 38(7):423-7. PubMed ID: 12821856
    [Abstract] [Full Text] [Related]

  • 2. Brain tumor enhancement in MR imaging at 3 Tesla: comparison of SNR and CNR gain using TSE and GRE techniques.
    Wintersperger BJ, Runge VM, Biswas J, Reiser MF, Schoenberg SO.
    Invest Radiol; 2007 Aug; 42(8):558-63. PubMed ID: 17620938
    [Abstract] [Full Text] [Related]

  • 3. The relationship between inflammation and atrophy in clinically isolated syndromes suggestive of multiple sclerosis: a monthly MRI study after triple-dose gadolinium-DTPA.
    Paolillo A, Piattella MC, Pantano P, Di Legge S, Caramia F, Russo P, Lenzi GL, Pozzilli C.
    J Neurol; 2004 Apr; 251(4):432-9. PubMed ID: 15083288
    [Abstract] [Full Text] [Related]

  • 4. Optimizing brain MRI protocols in the follow-up of patients with multiple sclerosis T2-weighted MRI of the brain after the administration of gadopentetate dimeglumine.
    Taschner CA, Kirsch EC, Scheffler K, Wetzel SG, Schulte-Mönting J, Kappos L, Radü EW.
    Magn Reson Imaging; 2005 Apr; 23(3):469-74. PubMed ID: 15862648
    [Abstract] [Full Text] [Related]

  • 5. Automatic detection of gadolinium-enhancing multiple sclerosis lesions in brain MRI using conditional random fields.
    Karimaghaloo Z, Shah M, Francis SJ, Arnold DL, Collins DL, Arbel T.
    IEEE Trans Med Imaging; 2012 Jun; 31(6):1181-94. PubMed ID: 22318484
    [Abstract] [Full Text] [Related]

  • 6. [The importance of magnetic field strength in the MR diagnosis of multiple sclerosis: a comparison of 0.5 and 1.5 T].
    Schima W, Wimberger D, Schneider B, Stiglbauer R, Asenbaum S, Imhof H.
    Rofo; 1993 Apr; 158(4):368-71. PubMed ID: 8477079
    [Abstract] [Full Text] [Related]

  • 7. Magnetic resonance imaging of the cranial nerves in the posterior fossa: a comparative study of t2-weighted spin-echo sequences at 1.5 and 3.0 tesla.
    Fischbach F, Müller M, Bruhn H.
    Acta Radiol; 2008 Apr; 49(3):358-63. PubMed ID: 18365827
    [Abstract] [Full Text] [Related]

  • 8. Gadolinium dose optimisation in patients with multiple sclerosis: intra- and inter-individual comparisons.
    Stecco A, Migazzo E, Saponaro A, Scarabino T, Tesser F, Monaco F, Carriero A.
    Eur J Radiol; 2006 Jan; 57(1):37-42. PubMed ID: 16040220
    [Abstract] [Full Text] [Related]

  • 9. Signal abnormalities on 1.5 and 3 Tesla brain MRI in multiple sclerosis patients and healthy controls. A morphological and spatial quantitative comparison study.
    Di Perri C, Dwyer MG, Wack DS, Cox JL, Hashmi K, Saluste E, Hussein S, Schirda C, Stosic M, Durfee J, Poloni GU, Nayyar N, Bergamaschi R, Zivadinov R.
    Neuroimage; 2009 Oct 01; 47(4):1352-62. PubMed ID: 19371784
    [Abstract] [Full Text] [Related]

  • 10. A novel method for automatic determination of different stages of multiple sclerosis lesions in brain MR FLAIR images.
    Khayati R, Vafadust M, Towhidkhah F, Nabavi SM.
    Comput Med Imaging Graph; 2008 Mar 01; 32(2):124-33. PubMed ID: 18055174
    [Abstract] [Full Text] [Related]

  • 11. Automated segmentation of multiple sclerosis lesion subtypes with multichannel MRI.
    Wu Y, Warfield SK, Tan IL, Wells WM, Meier DS, van Schijndel RA, Barkhof F, Guttmann CR.
    Neuroimage; 2006 Sep 01; 32(3):1205-15. PubMed ID: 16797188
    [Abstract] [Full Text] [Related]

  • 12. Enhancing lesions of the brain: intraindividual crossover comparison of contrast enhancement after gadobenate dimeglumine versus established gadolinium comparators.
    Essig M, Tartaro A, Tartaglione T, Pirovano G, Kirchin MA, Spinazzi A.
    Acad Radiol; 2006 Jun 01; 13(6):744-51. PubMed ID: 16679277
    [Abstract] [Full Text] [Related]

  • 13. Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron.
    Hammond KE, Metcalf M, Carvajal L, Okuda DT, Srinivasan R, Vigneron D, Nelson SJ, Pelletier D.
    Ann Neurol; 2008 Dec 01; 64(6):707-13. PubMed ID: 19107998
    [Abstract] [Full Text] [Related]

  • 14. Contrast enhancement and the acute lesion in multiple sclerosis.
    Rovaris M, Filippi M.
    Neuroimaging Clin N Am; 2000 Nov 01; 10(4):705-16 ,viii-ix. PubMed ID: 11359720
    [Abstract] [Full Text] [Related]

  • 15. Early contrast-enhanced magnetic resonance imaging with fluid-attenuated inversion recovery in multiple sclerosis.
    Kataoka H, Taoka T, Ueno S.
    J Neuroimaging; 2009 Jul 01; 19(3):246-9. PubMed ID: 19021828
    [Abstract] [Full Text] [Related]

  • 16. In vivo biochemical 7.0 Tesla magnetic resonance: preliminary results of dGEMRIC, zonal T2, and T2* mapping of articular cartilage.
    Welsch GH, Mamisch TC, Hughes T, Zilkens C, Quirbach S, Scheffler K, Kraff O, Schweitzer ME, Szomolanyi P, Trattnig S.
    Invest Radiol; 2008 Sep 01; 43(9):619-26. PubMed ID: 18708855
    [Abstract] [Full Text] [Related]

  • 17. T1-weighted fluid-attenuated inversion recovery and T1-weighted fast spin-echo contrast-enhanced imaging: a comparison in 20 patients with brain lesions.
    Al-Saeed O, Ismail M, Athyal RP, Rudwan M, Khafajee S.
    J Med Imaging Radiat Oncol; 2009 Aug 01; 53(4):366-72. PubMed ID: 19695043
    [Abstract] [Full Text] [Related]

  • 18. [Comparison of detection of brain lesions in multiple sclerosis in magnetic resonance imaging at magnetic field strength of 1.0 and 3.0 Tesla].
    Stosić-Opinćal T, Gavrilov M, Lavrnić S, Milenković R, Perić V, Gavrilović S, Jovancević M.
    Acta Chir Iugosl; 2007 Aug 01; 54(3):115-7. PubMed ID: 17988042
    [Abstract] [Full Text] [Related]

  • 19. [Cerebral and spinal MRI examination in patients with clinically isolated syndrome and definite multiple sclerosis].
    Sailer M, Fazekas F, Gass A, Kappos L, Radue EW, Rieckmann P, Toyka K, Wiendl H, Bendszus M.
    Rofo; 2008 Nov 01; 180(11):994-1001. PubMed ID: 18937154
    [Abstract] [Full Text] [Related]

  • 20. Detecting lesions in multiple sclerosis at 4.7 tesla using phase susceptibility-weighting and T2-weighting.
    Eissa A, Lebel RM, Korzan JR, Zavodni AE, Warren KG, Catz I, Emery DJ, Wilman AH.
    J Magn Reson Imaging; 2009 Oct 01; 30(4):737-42. PubMed ID: 19787716
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.